Related Experiment Video
Updated: Jun 6, 2025
09:02
Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation
Published on: November 26, 2018
21.0K
Increased c-MYC Expression Associated with Active IGH Locus Rearrangement: An Emerging Role for c-MYC in Chronic
Kenza Guiyedi1, Milène Parquet1, Said Aoufouchi2
1Centre National de la Recherche Scientifique (CNRS), Unité Mixte de Recherche (UMR) 7276/INSERM U1262, Université de Limoges, 87000 Limoges, France.
Cancers
|November 27, 2024
Summary
The c-MYC oncogene drives Chronic Lymphocytic Leukemia (CLL) progression by promoting cell proliferation and causing genetic instability. Targeting c-MYC may offer new therapeutic strategies for aggressive CLL.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Chronic Lymphocytic Leukemia (CLL) is a heterogeneous B-cell malignancy.
- The c-MYC oncogene plays a critical role in cell cycle regulation and proliferation.
- Overexpression of c-MYC is linked to aggressive disease phenotypes in various cancers.
Purpose of the Study:
- To review the role of c-MYC in Chronic Lymphocytic Leukemia (CLL).
- To elucidate how c-MYC overexpression contributes to genetic instability and disease progression in CLL.
- To explore c-MYC as a potential therapeutic target in CLL.
Main Methods:
- Literature review of studies investigating c-MYC in CLL.
- Analysis of molecular mechanisms linking c-MYC to genetic instability.
- Examination of the association between c-MYC expression and CLL aggressiveness.
Main Results:
- c-MYC is significantly overexpressed in CLL cases with unmutated IGHV genes.
- c-MYC overexpression leads to DNA damage, including double-strand breaks and chromosomal translocations.
- c-MYC drives both cell proliferation and genomic instability in CLL.
Conclusions:
- c-MYC plays a dual role in CLL, promoting proliferation and genomic instability.
- The oncogenic activity of c-MYC contributes to CLL progression and aggressiveness.
- Targeting c-MYC presents a promising therapeutic avenue for managing CLL.
Related Concept Videos
01:06Induced Pluripotent Stem Cells
3.9K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
3.9K
02:23Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
03:03mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
02:38Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
00:50Anaphase Promoting Complex
2.8K
The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
2.8K
02:15M-Cdk Drives Transition Into Mitosis
5.5K
Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
5.5K